IMRX
Immuneering·NASDAQ
--
--(--)
--
--(--)
8.36 / 10
Outperform
Sentiment is Outperform (8.36) with a unanimous Strong Buy from Needham. Fund‑flow score is 7.4 (good); overall inflow ratio 0.33, small‑cap inflow positive, larger blocks negative, indicating strong analyst optimism but mixed capital movements.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-09
InstitutionNeedham
Times predicted7
Historical Win Rate42.9%
What is the market sentiment for IMRX?
- IMRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.36/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
